83 results match your criteria: "From the Harvard Medical School[Affiliation]"

A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.

Neurol Neuroimmunol Neuroinflamm

November 2024

From the Harvard Medical School (M.S.S., T.C.); Department of Neurology (M.S.S., T.C.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (D.E.H., J.C.M.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurology and Program in Immunology (S.S.Z.), University of California at San Francisco; Department of Neurology (M.D.G.), Virginia Commonwealth University, Richmond; and Department of Neurology (C.R.), Columbia University, New York.

A 79-year-old woman presented with subacutely worsening headaches and right arm weakness. MRI showed diffuse pachymeningeal enhancement. Serologic workup revealed elevated erythrocyte sedimentation rate and C-reactive protein.

View Article and Find Full Text PDF

Background: Little is known about practice patterns and payments for immediate lymphatic reconstruction (ILR). This study aims to evaluate trends in ILR delivery and billing practices.

Methods: We queried the Massachusetts All-Payer Claims Database between 2016 and 2020 for patients who underwent lumpectomy or mastectomy with axillary lymph node dissection for oncologic indications.

View Article and Find Full Text PDF

Associations Between Ultra-Processed Food Consumption and Adverse Brain Health Outcomes.

Neurology

June 2024

From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham.

Background And Objectives: Ultra-processed foods (UPFs) are linked to cardiometabolic diseases and neurologic outcomes, such as cognitive decline and stroke. However, it is unclear whether food processing confers neurologic risk independent of dietary pattern information. We aimed to (1) investigate associations between UPFs and incident cognitive impairment and stroke and (2) compare these associations with other commonly recommended dietary patterns in the REasons for Geographic and Racial Differences in Stroke study.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the importance of imaging stewardship in emergency departments, focusing on a new survey spine MR imaging protocol aimed at suspected cord compression (CC) while minimizing unnecessary imaging.* -
  • Over 2000 patients were analyzed from 2018 to 2022, with a 14.2% positivity rate for CC among those examined; the protocol was significantly faster, averaging about 5 minutes and 50 seconds.* -
  • Key symptoms related to CC included trauma and various neurological issues, with most patients requiring surgical or medical management based on their findings.*
View Article and Find Full Text PDF

Association of Pharmacologic Treatment of Depression/Anxiety With Initial Patient-Reported Outcome Measures in Patients With Hip and Knee Osteoarthritis.

J Am Acad Orthop Surg

June 2024

From the Harvard Medical School, Boston, MA (Farid, Liimakka, and Parker), the Department of Orthopaedic Surgery, Division of Adult Reconstruction and Total Joint Arthroplasty, Brigham and Women's Hospital, Boston, MA (Liimakka, Chen, and Lange), the Department of Orthopaedic Surgery, Division of Foot and Ankle Surgery, Brigham and Women's Hospital, Boston, MA (Parker and Smith), and the Department of Orthopaedic Surgery, Hip & Knee Replacement Service, Massachusetts General Hospital, Boston, MA (Melnic).

Introduction: Depression and anxiety are common comorbidities that may exacerbate osteoarthritis (OA)-related pain. We aim to evaluate the effect of pharmacologic treatment of depression/anxiety on hip and knee patient-reported outcome measures (PROMs).

Methods: A multi-institutional PROMs database was queried for patients with depression or anxiety and hip or knee OA who completed a PROMs questionnaire at an initial orthopaedic visit between January 2015 and March 2023.

View Article and Find Full Text PDF

Background: The literature is meager regarding the natural history and outcomes of infantile hemangiomas (IHs) in the breast. Treatment in childhood may be considered due to psychosocial and physical concerns with breast development. Early surgical intervention may cause iatrogenic breast asymmetry and possibly impair lactation later in life.

View Article and Find Full Text PDF

Neuropathic pain (NP) underlies significant morbidity and disability worldwide. Although pharmacologic and functional therapies attempt to address this issue, they remain incompletely effective for many patients. Peripheral nerve surgeons have a range of techniques for intervening on NP.

View Article and Find Full Text PDF

Deoxycholic Acid for Dercum Disease: Repurposing a Cosmetic Agent to Treat a Rare Disease.

Cutis

April 2023

Ms. Silence, as well as Drs. Liteplo, McFadden, Al Jalbout, Al Saud, and Kourosh, are from the Massachusetts General Hospital, Boston. Ms. Silence and Dr. Kourosh are from the Department of Dermatology. Dr. Kourosh also is from the Harvard Medical School, Boston. Ms. Rice is from the University of Massachusetts Medical School, Worcester. Ms. Gao is from Harvard College, Boston.

Dercum disease is a rare condition characterized by multiple painful fatty tumors distributed throughout the body. There currently are no US Food and Drug Administration-approved treatments for Dercum disease, and the treatments tried have shown little to no efficacy, leaving many patients with a profoundly negative impact on quality of life. We present a case series of 3 patients who were diagnosed with Dercum disease and were treated with deoxycholic acid (DCA), a therapy approved for adipolysis of submental fat.

View Article and Find Full Text PDF

Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial.

J Am Coll Surg

August 2023

From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).

Background: The impact of abbreviated neoadjuvant regimens for HER2+ breast cancer on rates of breast conservation therapy (BCT) is unclear. We aimed to determine BCT rates in a single-arm prospective trial of neoadjuvant paclitaxel/trastuzumab/pertuzumab (THP) in patients with stage II or III HER2+ breast cancer.

Study Design: BCT eligibility was prospectively recorded before and after THP.

View Article and Find Full Text PDF

As value-based care gains traction in response to towering health care expenditures and issues of health care inequity, hospital capacity, and labor shortages, it is important to consider how a value-based approach can be achieved in plastic surgery. Value is defined as outcomes divided by costs across entire cycles of care. Drawing on previous studies and policies, this article identifies key opportunities in plastic surgery to move the levers of costs and outcomes to deliver higher value care.

View Article and Find Full Text PDF

Hospital Characteristics Associated with the Availability of Interventional Radiology Facilities and Services.

Radiology

April 2023

From the Harvard Medical School, Avenue Louis Pasteur, Boston, MA 02115 (T.C.H.); Harvard Business School, Boston, Mass (T.C.H.); Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Mass (C.B.W.); and Massachusetts Eye and Ear, Boston, Mass (C.B.W.).

View Article and Find Full Text PDF

Education Research: Neurologic Education in Physician Assistant Programs.

Neurol Educ

March 2023

From the Harvard Medical School (D.S.H., L.L., C.D.); Department of Neurology (D.S.H., M.N., A.B., L.L., C.D.), Brigham and Women's Hospital; Department of Neurology (D.S.H., K.S., L.L.), Massachusetts General Hospital, Boston; Department of Physician Assistant Studies (C.G.), Dominican University of California, San Rafael; and Department of Neurology (A.T.Y.), University of California San Francisco Medical Center.

Background And Objectives: A growing number of advanced practice providers (APPs) are entering neurologic practice, and educational initiatives focused on postgraduate training in neurology for these providers are growing in turn. Neurologic education in APP degree programs is not well defined, which limits the ability to tailor these initiatives to the specific needs of APPs. We aim to describe neurologic education in physician assistant (PA) degree programs to better inform these efforts.

View Article and Find Full Text PDF

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm

January 2023

From the Harvard Medical School (C.B., B.C.H., M.P.-T., C.R.G.G., R.B., H.L.W., T.C.); Ann Romney Center for Neurologic Diseases (C.B., B.C.H., Y.L., S.S., A.P., M.P.-T., C.R.G.G., R.B., H.L.W., T.C.), Brigham and Women's Hospital; Brigham Multiple Sclerosis Center (R.B., H.L.W., T.C.), Department of Neurology, Brigham and Women's Hospital; Center for Neurological Imaging (C.R.G.G.), Department of Radiology, Brigham and Women's Hospital; Biostatistics Center (B.C.H.), Massachusetts General Hospital, Boston, MA; and Novartis Pharma AG (H.K.), Basel, Switzerland.

Background And Objectives: Neurodegeneration and astrocytic activation are pathologic hallmarks of progressive multiple sclerosis (MS) and can be quantified by serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP). We investigated sNfL and sGFAP as tools for stratifying patients with progressive MS based on progression and disease activity status.

Methods: We leveraged our Comprehensive Longitudinal Investigation of MS at the Brigham and Women's Hospital (CLIMB) natural history study, which includes clinical, MRI data and serum samples collected over more than 20 years.

View Article and Find Full Text PDF

The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report.

J Addict Med

March 2023

From the Harvard Medical School, Boston, MA (JCM); and Division of Addiction Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (JCM, EH, LV).

Introduction: The current standard of care for physiological dependence to benzodiazepines requires prolonged outpatient tapers, which present challenges for patients and providers. Novel protocols for accelerated benzodiazepine tapers are needed. We describe a case of successful management of benzodiazepine withdrawal in the inpatient setting using a single, loading dose of phenobarbital with adjunctive valproate therapy.

View Article and Find Full Text PDF

Background: BIS (a brand of processed electroencephalogram [EEG] depth-of-anesthesia monitor) scores have become interwoven into clinical anesthesia care and research. Yet, the algorithms used by such monitors remain proprietary. We do not actually know what we are measuring.

View Article and Find Full Text PDF

Key Findings From Peer-Reviewed Published Research by the American Board of Physical Medicine and Rehabilitation in Review.

Am J Phys Med Rehabil

July 2022

From the Harvard Medical School, Boston, Massachusetts (SS); VA Boston Health Care System, Boston, Massachusetts (SS); American Board of Physical Medicine and Rehabilitation, Rochester, Minnesota (CLK, MMR); Mayo Clinic, Phoenix, Arizona (CLK); Mayo Clinic, Rochester, Minnesota (SWD); University of Texas Health Science Center, McGovern Medical School, Houston, Texas (GEF); TIRR Memorial Hermann Hospital, Houston, Texas (GEF); and University of Toronto, St John's Rehabilitation Hospital, Toronto, Ontario, Canada (LRR).

Recognizing the dearth of published research on board certification in physical medicine and rehabilitation and its subspecialties, the American Board of Physical Medicine and Rehabilitation has increased efforts to conduct and disseminate research in this area. This report summarizes key findings of peer-reviewed studies published by American Board of Physical Medicine and Rehabilitation staff and leadership in the past 6 yrs, including those conducted in partnership with other entities. The reported studies are organized in three main categories: initial certification, continuing certification, and subspecialty certification in physical medicine and rehabilitation.

View Article and Find Full Text PDF

Visual hallucinations are frequently encountered in clinical practice. It is critical for neurologists, particularly those in training, to develop a systematic approach for evaluating patients presenting with such unique and often perplexing symptoms. In this study, we present the case of a 48-year-old woman who developed vivid visual hallucinations after receiving nivolumab for melanoma.

View Article and Find Full Text PDF

Against Our Instincts: Decriminalization of Buprenorphine.

J Am Board Fam Med

April 2022

From the Harvard Medical School, Boston, MA (JCM, AC, WB); Baylor College of Medicine, Houston, TX (WB).

The rate of overdose deaths has increased dramatically over the past 2 decades. Recently, efforts have been made to expand access to medications for opioid use disorder, such as buprenorphine, by removing X-waiver training requirements. However, relieving such barriers has also raised concern about increasing diversion rates for buprenorphine use, defined as the use of buprenorphine for some purpose or by someone other than it was originally intended.

View Article and Find Full Text PDF